Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
about
Use of an allostatic neurotechnology by adolescents with postural orthostatic tachycardia syndrome (POTS) is associated with improvements in heart rate variability and changes in temporal lobe electrical activityEfficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
P2860
Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
@en
Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
@nl
type
label
Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
@en
Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
@nl
prefLabel
Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
@en
Understanding the placebo effect in clinical trials for postural tachycardia syndrome.
@nl
P2093
P2860
P356
P1476
Understanding the placebo effect in clinical trials for postural tachycardia syndrome
@en
P2093
Amy C Arnold
Bonnie K Black
Carlos Orozco
David Robertson
Italo Biaggioni
Satish R Raj
Victor C Nwazue
P2860
P304
P356
10.1111/1440-1681.12221
P577
2014-05-01T00:00:00Z